Confidential unit exclusion (CUE): Double edged sword for blood transfusion center: A ten-year study on volunteer blood donors in Kohgiluyeh and Boyer Ahmad province, Iran

被引:4
作者
Rad, Fariba [1 ,2 ]
Sajjadi, Seyed Mehdi [3 ]
Azizi, Arsalan [4 ]
Maghsudlu, Mahtab [5 ]
机构
[1] Yasuj Univ Med Sci, Cellular & Mol Res Ctr, Yasuj, Iran
[2] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran
[3] Birjand Univ Med Sci, Cellular & Mol Res Ctr, Birjand, Iran
[4] Yasuj Univ Med Sci, Cellular & Mol Res Ctr, Yasuj, Iran
[5] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran
关键词
Blood safety; Iranian Blood donors; Confidential unit exclusion; Sensitivity; Specificity; HEPATITIS-C; PREVALENCE; HIV;
D O I
10.1016/j.tracli.2019.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. - Confidential unit exclusion (CUE) is a mechanism developed in the1980s to increase blood safety by allowing donors to indicate confidentially if they think their blood is not safe for transfusion. While it has been used widely around the world, the efficacy of this strategy is still unclear. The present study evaluated the efficacy of the CUE system at the Blood Transfusion Center of Kohgiluyeh and Boyer Ahmad Province (KBTC), Iran by comparing the prevalence of transfusion-transmitted infectious (TTIs) in CUE and non-CUE groups. Methods. - This descriptive study used data from all volunteer blood donors over a ten-year period. Donors were classified in two groups: CUE and non-CUE. Screening tests were performed for hepatitis B surface antigens (HBs-Ag), hepatitis C virus antibody (HCV-Ab), and Human immunodeficiency virus antibody (HIV-Ab) and any repeatedly reactive results were confirmed by standard methods. Significant differences were determined by Chi(2) test. The sensitivity, specificity and PPV of the CUE system were also calculated. Results. - In the present study, the non-CUE and CUE groups consisted of 98.94% and 1.06% of volunteer blood donors, respectively. First-time donors selected the CUE option more often than repeated and regular donors. The prevalence of TTIs was significantly higher in the CUE group and CUE sensitivity, specificity, and PPV were 5.5%, 98.95%, and 0.96%, respectively. Conclusion. - We recommend the CUE system be pursued for further enhancement of blood safety. However, further studies are needed to establish the overall usefulness of this procedure throughout the whole country. (C) 2019 Societe francaise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:253 / 256
页数:4
相关论文
共 23 条
[1]  
Abolghasemi H, 2009, IRAN J PUBLIC HEALTH, V38, P82
[2]   Confidential unit exclusion and blood safety [J].
Alavian, Seyed Moayed .
SAO PAULO MEDICAL JOURNAL, 2011, 129 (05) :359-360
[3]  
Cheraghali AM, 2011, HEPAT MON, V11, P295
[4]   Test-seeking as motivation in volunteer blood donors [J].
Chiavetta, J ;
Ennis, M ;
Gula, CA ;
Baker, AD ;
Chambers, TL .
TRANSFUSION MEDICINE REVIEWS, 2000, 14 (03) :205-215
[5]   DONOR SELF-EXCLUSION PATTERNS AND HUMAN IMMUNODEFICIENCY VIRUS-ANTIBODY TEST-RESULTS OVER A 12-MONTH PERIOD [J].
CHIAVETTA, JA ;
NUSBACHER, J ;
WALL, A .
TRANSFUSION, 1989, 29 (01) :81-83
[6]   Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in Sao Paulo, Brazil: implications for modification of CUE polices in Brazil [J].
de Almeida-Neto, Cesar ;
Liu, Jing ;
Wright, David J. ;
Mendrone-Junior, Alfredo ;
Takecian, Pedro L. ;
Sun, Yu ;
Ferreira, Joao Eduardo ;
Fischer Chamone, Dalton de Alencar ;
Busch, Michael P. ;
Sabino, Ester Cerdeira .
TRANSFUSION, 2011, 51 (01) :191-197
[7]   Efficacy of the Confidential Unit Exclusion Option in Blood Donors in Tehran, Iran, Determined by Using the Nucleic Acid Testing Method in 2008-2009 [J].
Farhadi, Elham ;
Gharehbaghian, Ahmad ;
Karimi, Gharib ;
Samiee, Shahram ;
Tavasolli, Farzaneh ;
Salimi, Yahya .
HEPATITIS MONTHLY, 2011, 11 (11) :908-913
[8]  
Gonçalez Thelma T, 2011, Rev. Bras. Hematol. Hemoter., V33, P251, DOI 10.5581/1516-8484.20110068
[9]   Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007 [J].
Kafi-abad, S. Amini ;
Rezvan, H. ;
Abolghasemi, H. .
TRANSFUSION MEDICINE, 2009, 19 (04) :189-194
[10]   Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007 [J].
Kafi-Abad, Sedigheh Amini ;
Rezvan, Houri ;
Abolghasemi, Hassan ;
Talebian, Ali .
TRANSFUSION, 2009, 49 (10) :2214-2220